Search by keyword.
Technology limitations shouldn’t slow down your drug discovery ambitions. When timelines are tight, medicinal chemistry teams often encounter the same bottlenecks: limited synthetic flexibility, purification delays, and low productivity, particularly across emerging modalities.
The Hercules+™ solid-phase synthetic platform has been built to remove synthetic hurdles, accelerate timelines, and combine chemistry, technology, and modular workflows across all drug discovery programs, from small-molecule projects to linear (or cyclic) semi-peptides and peptides, as well as modalities such as molecular glues and drug conjugates (PROTACs, radiopharmaceuticals, etc.).
By combining versatile and robust synthetic capabilities with integrated purification workflows, the Hercules+™ enables scientists to routinely deliver focused libraries of tens to hundreds of analogues in 2-6 week cycles, enabling flexible collaboration models.
The Hercules+™ platform goes beyond peptide chemistry, leveraging over 12 validated reactions and a diverse toolbox of unique monomers to accelerate DMTA cycles and rapidly deliver drug-like candidates.
